share_log

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $3.5 Price Target

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $3.5 Price Target

HC Wainwright & Co.重申買入Kiora Pharmicals,維持3.5美元的目標價
Benzinga ·  2023/11/13 10:31

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $3.5 price target.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論